» Articles » PMID: 34795558

Role of Cleaved PINK1 in Neuronal Development, Synaptogenesis, and Plasticity: Implications for Parkinson's Disease

Overview
Journal Front Neurosci
Date 2021 Nov 19
PMID 34795558
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction plays a significant role in the pathogenesis of Parkinson's disease (PD). Consistent with this concept, loss of function mutations in the serine/threonine kinase- PINK1 (PTEN-induced putative kinase-1) causes autosomal recessive early onset PD. While the functional role of f-PINK1 (full-length PINK1) in clearing dysfunctional mitochondria via mitophagy is extensively documented, our understanding of specific physiological roles that the non-mitochondrial pool of PINK1 imparts in neurons is more limited. PINK1 is proteolytically processed in the intermembrane space and matrix of the mitochondria into functional cleaved products (c-PINK1) that are exported to the cytosol. While it is clear that posttranslational processing of PINK1 depends on the mitochondria's oxidative state and structural integrity, the functional roles of c-PINK1 in modulating neuronal functions are poorly understood. Here, we review the diverse roles played by c-PINK1 in modulating various neuronal functions. Specifically, we describe the non-canonical functional roles of PINK1, including but not limited to: governing mitochondrial movement, neuronal development, neuronal survival, and neurogenesis. We have published that c-PINK1 stimulates neuronal plasticity and differentiation via the PINK1-PKA-BDNF signaling cascade. In addition, we provide insight into how mitochondrial membrane potential-dependent processing of PINK1 confers conditional retrograde signaling functions to PINK1. Further studies delineating the role of c-PINK1 in neurons would increase our understanding regarding the role played by PINK1 in PD pathogenesis.

Citing Articles

Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells.

Yu S, Guo F, Luo Y, Zhang X, Wang C, Liu Y Molecules. 2024; 29(9).

PMID: 38731398 PMC: 11085363. DOI: 10.3390/molecules29091907.


Formoterol Acting via β2-Adrenoreceptor Restores Mitochondrial Dysfunction Caused by Parkinson's Disease-Related UQCRC1 Mutation and Improves Mitochondrial Homeostasis Including Dynamic and Transport.

Chang J, Chang H, Chao Y, Huang C, Lin C, Wu Z Biology (Basel). 2024; 13(4).

PMID: 38666843 PMC: 11048601. DOI: 10.3390/biology13040231.


Brain-derived neurotrophic factor protects neurons by stimulating mitochondrial function through protein kinase A.

Swain M, K Soman S, Tapia K, Dagda R, Dagda R J Neurochem. 2023; 167(1):104-125.

PMID: 37688457 PMC: 10543477. DOI: 10.1111/jnc.15945.


Mitochondrial calcium cycling in neuronal function and neurodegeneration.

Walters G, Usachev Y Front Cell Dev Biol. 2023; 11:1094356.

PMID: 36760367 PMC: 9902777. DOI: 10.3389/fcell.2023.1094356.


Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats.

Dagda R, Dagda R, Vazquez-Mayorga E, Martinez B, Gallahue A Int J Mol Sci. 2023; 24(1).

PMID: 36614135 PMC: 9820624. DOI: 10.3390/ijms24010690.

References
1.
Kawajiri S, Saiki S, Sato S, Hattori N . Genetic mutations and functions of PINK1. Trends Pharmacol Sci. 2011; 32(10):573-80. DOI: 10.1016/j.tips.2011.06.001. View

2.
Wang K, Steer E, Otero P, Bateman N, Cheng M, Scott A . PINK1 Interacts with VCP/p97 and Activates PKA to Promote NSFL1C/p47 Phosphorylation and Dendritic Arborization in Neurons. eNeuro. 2019; 5(6). PMC: 6377406. DOI: 10.1523/ENEURO.0466-18.2018. View

3.
Liu Y, Guardia-Laguarta C, Yin J, Erdjument-Bromage H, Martin B, James M . The Ubiquitination of PINK1 Is Restricted to Its Mature 52-kDa Form. Cell Rep. 2017; 20(1):30-39. PMC: 5745057. DOI: 10.1016/j.celrep.2017.06.022. View

4.
Biundo R, Weis L, Antonini A . Cognitive decline in Parkinson's disease: the complex picture. NPJ Parkinsons Dis. 2017; 2():16018. PMC: 5516581. DOI: 10.1038/npjparkd.2016.18. View

5.
Prasuhn J, Davis R, Kumar K . Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities. Front Cell Dev Biol. 2021; 8:615461. PMC: 7813753. DOI: 10.3389/fcell.2020.615461. View